News

Payal Sahni Becher is currently the Chief People Experience Officer & Executive VP at Pfizer Inc. She started this position in 2022. Prior to her current role, she obtained a graduate degree from ...
On 14 May 2025, the General Court of the EU ruled in favour of The New York Times in the much-awaited Pfizergate case, annulling the European Commission’s decision to withhold the SMS text messages ...
Firstrust Bank Executive Chairman and Owner Richard J. Green was recently honored as a recipient of a 2025 Ellis Island Medal ...
R&D Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and ...
The pharma giant entered an exclusive agreement with the Chinese biotech to gain rights to a cancer bispecific drug candidate.
Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...
This week's key events presented by Euronews' editor in chief of EU news Jeremy Fleming-Jones. View on euronews ...
Drugmaker's "three most senior" R&D officials "deliberately slow[ed] testing" so it would end after 2020 election, ex-official allegedly said. Spike protein persistence study author says took four ...
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...
Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...
On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.